Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)

Figure 11. Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)
(2012-2018)

Figure 11. Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)
(2012-2018)

Clinical trial data

Number of commercial clinical trials started in the UK, by year and phase (2012-2018)
Number of commercial clinical trial applications received by MHRA, by year (2013-2018)
Number of clinical trial applications received by MHRA in 2018, by phase and sponsor type
Number of commercial clinical trials started by country, Phase I (2012-2018)
Number of commercial clinical trials started by country, Phase II (2012-2018)
Number of commercial clinical trials started by country, Phase III (2012-2018)
Number of commercial clinical trials started in the UK, by year and disease area (2012-2018)
Number of commercial clinical trials started in oncology, by year and country (2012-2018)
Number of commercial clinical trials started in cardio-metabolic diseases, by year and country (2012-2018)
Number of commercial clinical trials started in nervous system diseases, by year and country (2012-2018)
Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)
Number of commercial clinical trials started in infectious diseases, by year and country (2012-2018)